Cargando…
A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer
BACKGROUND: To compare the efficiency and toxicity of bevacizumab by intrapleural or intravenous infusion in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer (NSCLC). METHODS: Sensitizing mutation negative NSCLC patients with malignant pleural effusion were ra...
Autores principales: | Nie, Keke, Zhang, Zhen, You, Yunhong, Zhuang, Xingjun, Zhang, Chunling, Ji, Youxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938744/ https://www.ncbi.nlm.nih.gov/pubmed/31726490 http://dx.doi.org/10.1111/1759-7714.13238 |
Ejemplares similares
-
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018) -
Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection
por: Zongwen, Sun, et al.
Publicado: (2017) -
S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer—A
Randomized Clinical Study
por: Nie, Keke, et al.
Publicado: (2020) -
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021)